Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Bilmen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cellular Signalling|September 11, 2002
Inhibition of the type 1 inositol 1,4,5-trisphosphate receptor by 2-aminoethoxydiphenylborateJonathan G Bilmen, Francesco Michelangeli
Brazilian Journal of Anesthesiology (Elsevier)|May 30, 2025
Keeping it in the family: Malignant Hyperthermia - how we predict, recognise and treat itJonathan G Bilmen, Pawan K Gupta
The Biochemical Journal|May 23, 2002
The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin AJonathan G Bilmen, Laura L Wootton, Francesco Michelangeli
Archives of Biochemistry and Biophysics|September 18, 2002
The mechanism of inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase by paxillineJonathan G Bilmen, Laura L Wootton, Francesco Michelangeli
Handbook of Clinical Neurology|November 22, 2018
Malignant hyperthermiaPhilip M Hopkins, Pawan K Gupta, Jonathan G Bilmen
European Journal of Biochemistry|August 3, 2002
Inhibition of SERCA Ca2+ pumps by 2-aminoethoxydiphenyl borate (2-APB). 2-APB reduces both Ca2+ binding and phosphoryl transfer from ATP, by interfering with the pathway leading to the Ca2+-binding sitesJonathan G Bilmen, Laura L Wootton, Rita E Godfrey, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 7, 2025
2-Hydroxypropyl-β-cyclodextrin, solubiliser in a novel dantrolene formulation: Its binding affinities to clinical compounds that may be used during anaesthesia or management of malignant hyperthermiaRichard H Ng Kwet Shing, David J Wright, Sandeep Pal, et al.
European Journal of Anaesthesiology|March 6, 2024
The novel rapid formulation of intravenous dantrolene (NPJ5008) versus standard dantrolene (Dantrium®): A clinical part-randomised phase 1 study in healthy volunteersRichard H Ng Kwet Shing, Lucy B Clayton, Samuel L Smith, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cellular Signalling|September 11, 2002
Inhibition of the type 1 inositol 1,4,5-trisphosphate receptor by 2-aminoethoxydiphenylborateJonathan G Bilmen, Francesco Michelangeli
Brazilian Journal of Anesthesiology (Elsevier)|May 30, 2025
Keeping it in the family: Malignant Hyperthermia - how we predict, recognise and treat itJonathan G Bilmen, Pawan K Gupta
The Biochemical Journal|May 23, 2002
The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin AJonathan G Bilmen, Laura L Wootton, Francesco Michelangeli
Archives of Biochemistry and Biophysics|September 18, 2002
The mechanism of inhibition of the sarco/endoplasmic reticulum Ca2+ ATPase by paxillineJonathan G Bilmen, Laura L Wootton, Francesco Michelangeli
Handbook of Clinical Neurology|November 22, 2018
Malignant hyperthermiaPhilip M Hopkins, Pawan K Gupta, Jonathan G Bilmen
European Journal of Biochemistry|August 3, 2002
Inhibition of SERCA Ca2+ pumps by 2-aminoethoxydiphenyl borate (2-APB). 2-APB reduces both Ca2+ binding and phosphoryl transfer from ATP, by interfering with the pathway leading to the Ca2+-binding sitesJonathan G Bilmen, Laura L Wootton, Rita E Godfrey, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 7, 2025
2-Hydroxypropyl-β-cyclodextrin, solubiliser in a novel dantrolene formulation: Its binding affinities to clinical compounds that may be used during anaesthesia or management of malignant hyperthermiaRichard H Ng Kwet Shing, David J Wright, Sandeep Pal, et al.
European Journal of Anaesthesiology|March 6, 2024
The novel rapid formulation of intravenous dantrolene (NPJ5008) versus standard dantrolene (Dantrium®): A clinical part-randomised phase 1 study in healthy volunteersRichard H Ng Kwet Shing, Lucy B Clayton, Samuel L Smith, et al.
Pageof 1